Ivermectin NDC 72888-207

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-207Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0207Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72888-207-09	72888020709	10 BLISTER PACK in 1 CARTON (72888-207-09) / 10 TABLET in 1 BLISTER PACK (72888-207-08)Marketed from Jan 22, 2025
72888-207-30	72888020730	30 TABLET in 1 BOTTLE (72888-207-30)Marketed from Jan 22, 2025
72888-207-66	72888020766	2 BLISTER PACK in 1 CARTON (72888-207-66) / 10 TABLET in 1 BLISTER PACKMarketed from Jan 22, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ivermectin
Generic name (nonproprietary): ivermectin
Active ingredients: Ivermectin — 6 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215922
Marketing start: Jan 22, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 72888-207_2cda4d15-1149-28c0-e063-6294a90a8736SPL ID 2cda4d15-1149-28c0-e063-6294a90a8736SPL set ID e88adfbc-e375-4fea-827e-6ec51ed6fd0aRxCUI 199998, 311207UNII 8883YP2R6DUPC 0372888206301
Pharmacologic class: Antiparasitic; Pediculicide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888020709 followed by a unit qualifier and the quantity

Package 72888-0207-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ivermectin tablets are indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract Ivermectin tablet is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis . This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin. (See CLINICAL PHARMACOLOGY , Clinical Studies .) Onchocerciasis. Ivermectin tablet is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus . This indication is based …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215922

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215922
Product	Strength	Form · route	Labeler	Product NDC
Ivermectin	Ivermectin 3 mg/1	TabletOral	Advagen Pharma Ltd	72888-206